Dr. William A. Conkright, MD

Dr. Conkright practices at Bozeman Health Deaconess Regional Medical Center in Bozeman, Montana, part of Bozeman Deaconess Health Services.

Dr. Conkright's NPI, 1316998362, was assigned on May 15, 2006. Dr. Conkright holds Montana license 118667.

Dr. Conkright's primary practice is Bozeman Health Deaconess Regional Medical Center, at 915 Highland Blvd, Bozeman, MT 59715 in Gallatin County. The practice phone is (406) 585-5000.

Dr. Conkright's primary practice is Bozeman Health Deaconess Regional Medical Center in Bozeman, Montana, part of Bozeman Deaconess Health Services. Dr. Conkright is also affiliated with St. James Hospital. The medical group on file is Bozeman Health. Dmand AI also links Dr. Conkright to 3 more hospitals and 1 group practice or clinic, each named with a free account. Dr. Conkright's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Conkright practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Conkright's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Conkright's licenses on file in 4 states: Montana, Kentucky, Tennessee and Wisconsin.

CMS data shows 909 Medicare services from Dr. Conkright across 8 procedure codes in 2024, for 271 Medicare patients. Medicare paid $65,193 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 271 Medicare patients who saw Dr. Conkright in 2024. The largest group is 65 to 74, with 128 patients. 63% of them have high blood pressure, and 60% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Conkright's median patient age at 74, with 51% women.

In 2024, Dr. Conkright wrote 740 Medicare Part D claims for 128 patients. 81% of them were for generic drugs. CMS names the drug for 522 of them, across 20 drugs with 11 or more claims each, at $751,070 in total drug cost. In 2023, CMS named 275 claims across 13 drugs.

Dr. Conkright accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Conkright as offering telehealth.

Dmand AI links 1 paper to Dr. Conkright in 2014. Dr. Conkright's most frequent co-author is Ari D. Baron, MD.

Dmand AI links Dr. Conkright to 11 clinical trials, 7 of them phase 3 studies. 11 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Breast Neoplasms. National Cancer Institute (NCI) sponsors the most, 7. Open Payments lists research payments to Dr. Conkright that name 1 trial.

CMS Open Payments shows 128 general payments to Dr. Conkright from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Celgene Corporation paid the most, $256. It also lists 4 research payments totaling $8,870 in 2019, naming 1 clinical trial.